Anke Klippel

Title: Anke Klippel: Innovator in Cancer Research

Introduction

Anke Klippel is a prominent inventor based in Westfield, NJ (US). She has made significant contributions to the field of cancer research, particularly through her innovative patents. With a total of 3 patents, her work focuses on advancing treatment options for cancer patients.

Latest Patents

One of her latest patents is titled "Transgenic mouse expressing human cereblon." This patent provides transgenic mice whose genome comprises a nucleic acid sequence encoding human cereblon (CRBN) or a fragment thereof, wherein endogenous mouse CRBN is not expressed in the transgenic mice. The patent also includes cells, cell lines, tissues, and organs derivable from the transgenic mice, along with methods for producing and using such mice. Another significant patent is "TIM-3 antagonists for the treatment and diagnosis of cancers." This patent outlines methods for treating a subject afflicted with cancer by administering a TIM3 agonist, such as an anti-TIM3 antibody, either alone or in conjunction with another immune checkpoint inhibitor. It also provides methods for assessing the efficacy of treatment with a TIM3 antagonist in subjects afflicted with cancer.

Career Highlights

Anke Klippel has worked with notable companies in the pharmaceutical industry, including Celgene Corporation and Bristol-Myers Squibb Company. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in cancer therapies.

Collaborations

Throughout her career, Anke has collaborated with esteemed colleagues, including Rajesh Chopra and Kyle MacBeth. These collaborations have further enhanced her research and innovation in the field.

Conclusion

Anke Klippel's contributions to cancer research through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in cancer treatment and diagnosis.